SPY386.54-3.04 -0.78%
DIA314.19-1.40 -0.44%
IXIC13,358.79-230.04 -1.69%

Credit Suisse Maintains Neutral on Gilead Sciences, Raises Price Target to $66

Credit Suisse analyst Evan Seigerman maintains Gilead Sciences (NASDAQ:GILD) with a Neutral and raises the price target from $65 to $66.

· 02/05/2021 09:49
Credit Suisse analyst Evan Seigerman maintains Gilead Sciences (NASDAQ:GILD) with a Neutral and raises the price target from $65 to $66.